Applied Biosystems, Amaxa, and Invitrogen Lead Attractive Gene
Silencing Market - Revealed in New Life Science Dashboard™
Market Research Report
Interest in Switching Suppliers Up Significantly Compared to
2007 Life Science Dashboard™
from Percepta Associates
CARLSBAD, Calif. (Business Wire EON/PRWEB ) October 6, 2008 --
Today Percepta
Associates released Series Two of its Gene
Silencing Life Science Dashboard™
market research report. This market research report, which
analyzes key
market indicators, such as market size and market growth rate,
for specific gene silencing segments, reveals that Applied
Biosystems (NYSE:ABI), Amaxa (SWX:Lonn) and Invitrogen (NASDAQ:IVGN),
are leading suppliers of research products and kits for gene silencing
and gene knockdown researchers. ThermoFisher Scientific
(NYSE:TMO), Sigma-Aldrich (NASDAQ:SIAL), Roche Applied Sciences, a
division of Roche Diagnostics (VTX:ROG.VX), Bio-Rad Laboratories
(AMEX:BIO) and Qiagen (NASDAQ:QGEN) share leadership in specific gene
silencing application segments in this 2008 report. Gene
silencing is a powerful method of artificially inducing a shutdown of
specific targeted genes expressed in cells. Gene silencing
methods are increasingly used in gene function studies, drug target
validation, and the development of therapeutics.
Product application segments analyzed in this new Gene
Silencing Life Science Dashboard™
are:
-
RNAi screens using siRNA libraries
-
In vivo induction of siRNA from a plasmid
-
In vivo digestion of long dsRNA using dicer enzymes
-
Expression of siRNA in vitro
-
Use of PCR mediated expression cassettes to generate siRNAs
-
Instrument-mediated delivery of synthetic siRNA into cells
-
Lipid-mediated delivery of synthetic siRNA into cells
-
Instrument-mediated delivery of plasmid encoding siRNA into cells
-
Lipid-mediated delivery of plasmid encoding siRNA into cells
-
Viral delivery of siRNA vectors into cells
-
Use of reporter systems to track gene knockdown
Drawing comparisons to the findings of Series One Gene Silencing
dashboard, published in February 2007, Percepta
reports a growing dissatisfaction among researchers using gene silencing
products. Greater than 50% of researchers surveyed,
spanning all 11 application segments analyzed, indicated that they would
be willing to switch products or suppliers for better performance,
service, or price. This is a measurable shift from last year’s
dashboard where only 5 of 10 segments showed similar willingness to
switch products or suppliers.
“Generally, once a scientist
has a method working they are reticent to switch the reagents they are
using,” said Mike Klein of
Percepta. “The fact that more
than half of the surveyed researchers that use siRNA products are
willing to switch suggest there is a considerable level of
dissatisfaction in this market. This presents an
opportunity for all suppliers to review their product offering and if
necessary make incremental improvements to gain share. This is why Percepta’s
Life Sciences Dashboards™
regularly include this type of bellwether information.”
To view gene silencing market research sample
data and questionnaire
visit: www.perceptaassociates.com/publications/gene_silencing_overview.shtml
Life
Science Dashboards™
are readily accessible sources of current, segment-specific, market
research. Designed and implemented by industry veterans, each dashboard
provides key life science market indicators compiled from the survey
responses of qualified decision-makers and researchers actively using
life science research products.
Unlike other market research reports, Percepta's dashboards
feature an “at-a-glance”
format that provides rapid access to actionable key market indicators in
an easy to understand framework, including:
-
Market share
-
Market growth and reaction throughput rates
-
Customer satisfaction
-
Propensity to switch
-
Competitive intensity
-
Perceived pricing
-
Top suppliers
-
Technique usage frequency
-
Fastest growing techniques
-
Primary and secondary downstream applications
About Percepta
Founded in 2005 in Carlsbad, California Percepta Associates serves
a rapidly growing roster of global bioscience clients. Percepta is a
specialized consultancy providing expert market research, strategic
business planning, portfolio management, product and corporate branding
and marketing communications services. For more information visit www.perceptaassociates.com
See the original story at: http://eon.businesswire.com/releases/gene_silencing/life_science/prweb1432974.htm
Post Comment: Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1UaGlyLUZhbHUtRmFsdS1IYWxmLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|